#clinical trial — Tuesday, July 07, 2026 (1 items)
| 0 | 💬 0 |
Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trial.
(nature.com)
|
Nature Medicine 2026-07-07 | #antibody #hiv #clinical trial #immunotherapy #vaccination |